Inavisis, Inc. Launches Licensing Program for Degenerative Spinal Discs

SAN DIEGO - May 2, 2015 - PRLog -- Inavisis, Inc. announced today that they are launching a premier licensing program for a portfolio of patents consisting of 14 issued and one pending U.S. patent on behalf of BSNC Holding, LLC. A full licensing campaign has been developed to provide exclusive and non-exclusive license agreements on fair, reasonable and non-discriminatory terms for the biologic treatment of degenerative spinal disc market application.

BSNC Holding, LLC owns a comprehensive portfolio of patents that covers the composition, method, process, device and kit to deliver biologics comprising fibrinogen and thrombin to act as an adhesive and sealant for spinal disc repair. Sometimes referred to as a “fix-a-flat” method for the spinal disc, the technology has demonstrated to provide benefits to degenerated spinal discs and has the potential for groundbreaking advances for the alleviation of acute and chronic pain caused by the degeneration of spinal discs.  The technology has the added benefit to act as a delivery, carrier and containment mechanism for active healing ingredients such as stem cells to the spinal discs. This technology utilizes fibrin to act as an adhesive and scaffolding that fills the voids of herniated and/or degenerated spinal discs. The composition and method are not limited to spinal discs and could be implemented in other market applications.

Sam Khoury, PHD, MBA, president of Inavisis, Inc. is a leading expert with over 25 years experience in technology monetization.  Dr. Khoury states, “The broad uses and strong claims of this patent portfolio will provide the right company with a strong market position for delivering pain control and healing medication to the right location in a spinal injury case.”

Mr. Brian Burkinshaw, Managing Partner of BSNC Holding, LLC stated that “We are excited that this comprehensive patent portfolio will be offered to companies that are involved in degenerative spinal disc treatment and delivery of biologics areas of practice.”

BSNC Holding, LLC
BSNC Holding, LLC, headquartered in Pflugerville, Texas (near Austin) is a holding company that holds, manages, licenses and otherwise commercially markets patents and other intellectual property conveyed to the company by its members. BSNC members bring in excess of 30 years of experience in the development and commercialization of new medical devices and technology.

Inavisis, Inc.

Inavisis, Inc., headquartered in San Diego, California is a leading intellectual property corporation that creates strategic licensing campaigns based on a focused technology leveraging strategy that has been perfected over the past 25 years. INAVISIS^® was established in January 2000 and became a premier intellectual property boutique specializing in valuation, licensing and enforcement of intellectual properties generating millions of dollars from leveraging the patent portfolios of fortune 500 companies. For more information please visit www.inavisis.com.

INAVISIS^® is a registered trademark of Inavisis, Inc.